FDA Tells 5th Circuit Mifepristone Changes Are Based On Data, Medical Literature
WASHINGTON, D.C. — The Food and Drug Administration lawfully changed the conditions of use for the abortion drug mifepristone by relying on decades of data and published medical literature, the agency...To view the full article, register now.
Already a subscriber? Click here to view full article